{"id":411433,"date":"2021-01-08T19:18:14","date_gmt":"2021-01-09T00:18:14","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=411433"},"modified":"2021-01-08T19:18:14","modified_gmt":"2021-01-09T00:18:14","slug":"rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\/","title":{"rendered":"ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action – FBIO"},"content":{"rendered":"
\n

NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. (NASDAQ: FBIO) between December 11, 2019 and October 9, 2020, inclusive (the “Class Period”), of the important January 26, 2021 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Fortress investors under the federal securities laws.<\/p>\n

To join the Fortress class action, go to http:\/\/www.rosenlegal.com\/cases-register-1997.html<\/a> or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com<\/a> or cases@rosenlegal.com<\/a> for information on the class action.<\/p>\n

According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that: (1) intravenous (\u201cIV\u201d) Tramadol was not safe for the intended patient population; (2) as a result, it was foreseeable that the U.S. Food and Drug Administration would not approve the New Drug Application for IV Tramadol; and (3) as a result, defendants\u2019 public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.<\/p>\n

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 26, 2021<\/strong>. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http:\/\/www.rosenlegal.com\/cases-register-1997.html<\/a> or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com<\/a> or cases@rosenlegal.com<\/a>.<\/p>\n

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. AN INVESTOR\u2019S ABILITY TO SHARE IN ANY POTENTIAL FUTURE RECOVERY IS NOT DEPENDENT UPON SERVING AS LEAD PLAINTIFF.<\/p>\n

Follow us for updates on LinkedIn: https:\/\/www.linkedin.com\/company\/the-rosen-law-firm<\/a>, on Twitter: https:\/\/twitter.com\/rosen_firm<\/a> or on Facebook: https:\/\/www.facebook.com\/rosenlawfirm\/<\/a>.<\/p>\n

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 3 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm\u2019s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.<\/p>\n

Contact Information:<\/p>\n

\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Laurence Rosen, Esq.
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Phillip Kim, Esq.
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0The Rosen Law Firm, P.A.
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0275 Madison Avenue, 40th Floor
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0New York, NY 10016
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Tel: (212) 686-1060
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Toll Free: (866) 767-3653
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Fax: (212) 202-3827
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0lrosen@rosenlegal.com<\/a>
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0pkim@rosenlegal.com<\/a>
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0cases@rosenlegal.com<\/a>
\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0www.rosenlegal.com<\/a><\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. (NASDAQ: FBIO) between December 11, 2019 and October 9, 2020, inclusive (the “Class Period”), of the important January 26, 2021 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Fortress investors under the federal securities laws. To join the Fortress class action, go to http:\/\/www.rosenlegal.com\/cases-register-1997.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that: (1) intravenous (\u201cIV\u201d) Tramadol was … <\/p>\n

Continue reading “ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action – FBIO”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-411433","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action - FBIO - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action - FBIO - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. (NASDAQ: FBIO) between December 11, 2019 and October 9, 2020, inclusive (the “Class Period”), of the important January 26, 2021 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Fortress investors under the federal securities laws. To join the Fortress class action, go to http:\/\/www.rosenlegal.com\/cases-register-1997.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that: (1) intravenous (\u201cIV\u201d) Tramadol was … Continue reading "ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action – FBIO"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-09T00:18:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzA0MyMzOTExMjI1IzIwMjA0MTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action – FBIO\",\"datePublished\":\"2021-01-09T00:18:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\\\/\"},\"wordCount\":532,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMzA0MyMzOTExMjI1IzIwMjA0MTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\\\/\",\"name\":\"ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action - FBIO - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMzA0MyMzOTExMjI1IzIwMjA0MTE=\",\"datePublished\":\"2021-01-09T00:18:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMzA0MyMzOTExMjI1IzIwMjA0MTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMzA0MyMzOTExMjI1IzIwMjA0MTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action – FBIO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action - FBIO - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\/","og_locale":"en_US","og_type":"article","og_title":"ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action - FBIO - Market Newsdesk","og_description":"NEW YORK, Jan. 08, 2021 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fortress Biotech, Inc. (NASDAQ: FBIO) between December 11, 2019 and October 9, 2020, inclusive (the “Class Period”), of the important January 26, 2021 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Fortress investors under the federal securities laws. To join the Fortress class action, go to http:\/\/www.rosenlegal.com\/cases-register-1997.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that: (1) intravenous (\u201cIV\u201d) Tramadol was … Continue reading \"ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action – FBIO\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-09T00:18:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzA0MyMzOTExMjI1IzIwMjA0MTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action – FBIO","datePublished":"2021-01-09T00:18:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\/"},"wordCount":532,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzA0MyMzOTExMjI1IzIwMjA0MTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\/","name":"ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action - FBIO - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzA0MyMzOTExMjI1IzIwMjA0MTE=","datePublished":"2021-01-09T00:18:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzA0MyMzOTExMjI1IzIwMjA0MTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzA0MyMzOTExMjI1IzIwMjA0MTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rosen-globally-respected-investor-counsel-reminds-fortress-biotech-inc-investors-of-important-deadline-in-securities-class-action-fbio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Reminds Fortress Biotech, Inc. Investors of Important Deadline in Securities Class Action – FBIO"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/411433","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=411433"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/411433\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=411433"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=411433"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=411433"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}